Testosterone Replacement Therapy (TRT) Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast 2024-2028

Published: Nov 2023 Pages: 167 SKU: IRTNTR45364

Testosterone Replacement Therapy (TRT) Market 2024-2028

The Testosterone Replacement Therapy (TRT) Market size is estimated to grow by USD 497.67 million at a CAGR of 3.7% between 2023 and 2028. 

Increased awareness about hypogonadism among the public and primary care physicians will drive revenue growth in the testosterone replacement therapy (TRT) market. Globally, different organizations are working on initiatives to increase patient awareness of hypogonadism and available treatment options. For instance, companies such as Auxilium Pharmaceuticals initiated a low testosterone awareness campaign. Also, organizations like the Endocrine Society undertake initiatives to increase awareness about hypogonadism among medical professionals. Due to increasing awareness of treatment options, a significant number of people are proactively approaching fertility care centres and medical practitioners to undertake testosterone replacement therapy, which is driving the demand for testosterone replacement therapy products, such as topical products, injectables, and oral capsules, globally. Therefore, rising initiatives to increase awareness about hypogonadism among people will drive market growth during the forecast period. 

Technavio has segmented the market into Distribution Channel, Product and Geography

  • The distribution Channel segment is classified into hospitals, retail, and online
  • The product  segment is classified into injectables, topicals, and others
  • The geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018 - 2022, besides analyzing the current market scenario.

What will be the Size of the Testosterone Replacement Therapy Market During the Forecast Period?

To learn more about this report, Request Free Sample

Testosterone Replacement Therapy Market Segmentation by Distribution Channel, Product and Geography Analysis

Distribution Channel Analysis 

Hospitals

The market share growth by the hospitals segment will be significant during the forecast period. The hospital segment comprises pharmaceuticals that are purchased directly by hospitals from different pharmaceutical companies and used for the treatment of either outpatients or inpatients. Testosterone replacement therapy products such as injectables, topicals, and drugs are found in hospital pharmacies.

Get a glance at the market contribution of various segments Download PDF Sample

The hospitals segment was the largest and was valued at USD 1,164.50 million in 2018. In 2023, the hospitals segment held the largest market share based on the distribution channel and will continue to dominate the testosterone replacement therapy (TRT) market. Hospital pharmacies may provide advice on drug dosages, interactions, and potential side effects, as well as monitor patient adherence to medication regimens. This can help in improving patient outcomes. Moreover, hospital pharmacies also play a key role in clinical trials. Clinical trials are conducted to test the safety and efficacy of new drugs, and hospital pharmacies are often involved in the preparation and dispensing of medications used in these trials. By participating in clinical trials, hospital pharmacies contribute to the development of new drugs. All such factors make hospital pharmacy a critical channel that drives segment growth. This, in turn, is expected to drive the growth of the market during the forecast period.

Product Analysis 

Injectables

The injectables segment is witnessing steady growth, owing to the availability of patient assistance programs and their direct administration benefits. Pfizer, one of the leading vendors, provides Depo-Testosterone, which is an androgen that is prescribed for male replacement therapy in circumstances where there are signs of endogenous testosterone insufficiency or absence through the Pfizer Savings Program. Another major factor associated with the growth of this segment is the increase in the prevalence of testosterone deficiency. Obesity, diabetes, dyslipidemia, and metabolic syndrome are the major conditions that are identified as risk factors for testosterone deficiency. Therefore, the increase in the prevalence of testosterone deficiency is expected to accelerate the growth of the testosterone replacement therapy (TRT) market during the forecast period. 

Topicals

Topical treatments for testosterone deficiency include gels and patches. Topical products offer several benefits over injectable products, such as easy application and use and pain-free treatment. Moreover, the absorption process through the skin causes fluctuations in testosterone levels, which closely mimics the natural process in the human body, providing safer administration. Furthermore, the increasing availability of gel-based products is driving the revenue growth of the topical segment during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 57% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. North America is a dominating region in the testosterone replacement therapy market with the US and Canada being the leading revenue-generating countries. The presence of key players ensures the easy availability of new and improved products in the region. Moreover, the increasing cases of hypogonadism and raising awareness about the treatment of testosterone deficiency and erectile dysfunction are promoting growth in testosterone replacement therapies. About 10% of males in the US have infertility. Testosterone deficiency due to hypogonadism is among the primary causes of such complications.

For instance, according to Boston University, an estimated 4 to 5 million men in the US get affected by hypogonadism every year. People are coming forward to seek treatment, owing to which patients undergoing testosterone replacement therapies are increasing in the region. This is expected to drive the growth of the regional market during the forecast period.

Buy Full Report Now

Key Testosterone Replacement Therapy Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 19 market companies, including:

AbbVie Inc. - The company offers testosterone replacement therapy such as Androderm.

  • Acerus Pharmaceuticals Corp.
  • Actiza Pharmaceutical Pvt. Ltd.
  • Alembic Pharmaceuticals Ltd.
  • Amneal Pharmaceuticals Inc.
  • Bausch Health Companies Inc.
  • Bayer AG, Cipla Ltd.
  • Eli Lilly and Co.
  • Endo International Plc
  • Ferring BV
  • Halozyme Therapeutics Inc.
  • Insud Pharma S.L
  • Lupin Ltd.
  • Marius Pharmaceuticals
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.,
  • Acrux Ltd.
  • Alvogen Iceland ehf
  • Sawai Pharmaceutical Co. Ltd.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Testosterone Replacement Therapy Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. 

Key Testosterone Replacement Therapy Market Drivers

The increasing aging population and postmenopausal women are notably driving the market growth. Menopausal-related medical conditions are treated with hormone replacement therapy drugs such as estrogen, progesterone, and others. For instance, over 50% of those over 65 in February 2021, or over 9% of the population, were women, according to the United Nations Economic and Social Commission for Asia and the Pacific, a regional organization with its regional headquarters in Thailand. This percentage is anticipated to increase by 18% by 2050. The percentage of adults over 80 will nearly triple, from 1.7% to 4.9% of the population, with women making up more than 60% of this group. Older women may be more vulnerable to menopausal-related medical conditions than older men for a variety of reasons.

Moreover, the market for drugs used in hormonal replacement therapy is, therefore, driven by the growing number of women experiencing menopausal symptoms and the aging population. Thus, the increasing aging population and postmenopausal women are the major factors that are expected to boost the growth of the global testosterone replacement therapy (TRT) market during the forecast period.

Significant Testosterone Replacement Therapy Market Trends

The rise in novel therapeutic approaches for testosterone replacement therapy is an emerging trend shaping the market growth. The testosterone replacement therapy market has witnessed a rise in novel therapeutic approaches to treat low testosterone deficiency. Metabolic syndrome can lead to testosterone deficiency. Metabolic syndrome is treated with anti-inflammatory drugs, which can also be used to treat testosterone deficiency. For instance, at an Endocrine Society annual meeting, Dr. Fahim Ebrahimi presented the results of a recent study that analyzed the therapeutic effects of Anakinra on the testosterone levels of individuals with metabolic syndrome. According to the results, testosterone levels rose by 11% in the treatment group. 

However, the growing focus of companies toward such therapeutic approaches is expected to contribute to the entry of new products in the testosterone replacement therapy (TRT) market. Thus, the rise in novel therapeutic approaches is one of the major trends that is expected to boost the growth of the testosterone replacement therapy (TRT) market during the forecast period.

Major Testosterone Replacement Therapy Market Challenges

The adverse effects of testosterone replacement therapy are a significant challenge hindering market growth. Testosterone replacement therapy is being approved by the US FDA and is indicated to treat disorders associated with low levels of testosterone. However, the injectables, topicals, implants, and oral capsule-based products indicated for use in testosterone replacement therapy have been associated with being the primary cause of several adverse events. Potential adverse effects of testosterone replacement therapies are the risk of cardiovascular diseases, risk of prostate cancer, and obstructive sleep apnea. As per the US FDA, older men undergoing testosterone were at risk of a heart attack. Moreover, testosterone therapy increases the risk of stroke in aged men.

Furthermore, products used for testosterone replacement therapies are found to increase the risk of cerebrovascular accidents, which leads to stroke in individuals. Therefore, such adverse effects associated with testosterone replacement therapies can decrease patient compliance, which can become a major challenge for the growth of the testosterone replacement therapy (TRT) market. Therefore such factors are expected to hinder the market growth during the forecast period. 

Buy Now Full Report

Key Testosterone Replacement Therapy Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Testosterone Replacement Therapy Market Customer Landscape

Segment Overview

The testosterone replacement therapy market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028. 

  • Distribution Channel Outlook
    • Hospitals
    • Retail
    • Online
  • Product Outlook
    • Injectables
    • Topicals
    • Others
  • Region Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest Of World 
      • Saudi Arabia
      • South Africa
      • Rest of the Middle East & Africa

Testosterone Replacement Therapy Market Scope

Report Coverage

Details

Page number

167

Base year

2023

Historic period

 2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 3.7%

Market Growth 2024-2028

USD 497.67 million

Market structure

Fragmented

YoY growth 2023-2024(%)

3.13

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 57%

Key countries

US, Canada, Germany, UK, and China

Competitive landscape

Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

AbbVie Inc., Acerus Pharmaceuticals Corp., Actiza Pharmaceutical Pvt. Ltd., Alembic Pharmaceuticals Ltd., Amneal Pharmaceuticals Inc., Bausch Health Companies Inc., Bayer AG, Cipla Ltd., Eli Lilly and Co., Endo International Plc, Ferring BV, Halozyme Therapeutics Inc., Insud Pharma S.L, Lupin Ltd., Marius Pharmaceuticals, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Acrux Ltd., Alvogen Iceland ehf, and Sawai Pharmaceutical Co. Ltd.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period. 

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Testosterone Replacement Therapy Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of testosterone replacement therapy between 2024 and 2028
  • Precise estimation of the testosterone replacement therapy market size and its contribution of the market in focus to the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of testosterone replacement therapy market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global testosterone replacement therapy market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global testosterone replacement therapy market 2018 - 2022 ($ million)
    • 4.2 Distribution Channel Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – Distribution Channel Segment 2018 - 2022 ($ million)
    • 4.3 Product Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – Product Segment 2018 - 2022 ($ million)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Distribution Channel

    • 6.1 Market segments
      • Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
    • 6.2 Comparison by Distribution Channel
      • Exhibit 32: Chart on Comparison by Distribution Channel
      • Exhibit 33: Data Table on Comparison by Distribution Channel
    • 6.3 Hospitals - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
      • Exhibit 35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
      • Exhibit 36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
    • 6.4 Retail - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Retail - Market size and forecast 2023-2028 ($ million)
      • Exhibit 39: Data Table on Retail - Market size and forecast 2023-2028 ($ million)
      • Exhibit 40: Chart on Retail - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Retail - Year-over-year growth 2023-2028 (%)
    • 6.5 Online - Market size and forecast 2023-2028
      • Exhibit 42: Chart on Online - Market size and forecast 2023-2028 ($ million)
      • Exhibit 43: Data Table on Online - Market size and forecast 2023-2028 ($ million)
      • Exhibit 44: Chart on Online - Year-over-year growth 2023-2028 (%)
      • Exhibit 45: Data Table on Online - Year-over-year growth 2023-2028 (%)
    • 6.6 Market opportunity by Distribution Channel
      • Exhibit 46: Market opportunity by Distribution Channel ($ million)
      • Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million)

    7 Market Segmentation by Product

    • 7.1 Market segments
      • Exhibit 48: Chart on Product - Market share 2023-2028 (%)
      • Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
    • 7.2 Comparison by Product
      • Exhibit 50: Chart on Comparison by Product
      • Exhibit 51: Data Table on Comparison by Product
    • 7.3 Injectables - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Injectables - Market size and forecast 2023-2028 ($ million)
      • Exhibit 53: Data Table on Injectables - Market size and forecast 2023-2028 ($ million)
      • Exhibit 54: Chart on Injectables - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Injectables - Year-over-year growth 2023-2028 (%)
    • 7.4 Topicals - Market size and forecast 2023-2028
      • Exhibit 56: Chart on Topicals - Market size and forecast 2023-2028 ($ million)
      • Exhibit 57: Data Table on Topicals - Market size and forecast 2023-2028 ($ million)
      • Exhibit 58: Chart on Topicals - Year-over-year growth 2023-2028 (%)
      • Exhibit 59: Data Table on Topicals - Year-over-year growth 2023-2028 (%)
    • 7.5 Others - Market size and forecast 2023-2028
      • Exhibit 60: Chart on Others - Market size and forecast 2023-2028 ($ million)
      • Exhibit 61: Data Table on Others - Market size and forecast 2023-2028 ($ million)
      • Exhibit 62: Chart on Others - Year-over-year growth 2023-2028 (%)
      • Exhibit 63: Data Table on Others - Year-over-year growth 2023-2028 (%)
    • 7.6 Market opportunity by Product
      • Exhibit 64: Market opportunity by Product ($ million)
      • Exhibit 65: Data Table on Market opportunity by Product ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 67: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 68: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 69: Chart on Geographic comparison
      • Exhibit 70: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 Canada - Market size and forecast 2023-2028
      • Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
      • Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
      • Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
    • 9.9 Germany - Market size and forecast 2023-2028
      • Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.10 UK - Market size and forecast 2023-2028
      • Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
      • Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
      • Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
      • Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 9.11 China - Market size and forecast 2023-2028
      • Exhibit 103: Chart on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 104: Data Table on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 105: Chart on China - Year-over-year growth 2023-2028 (%)
      • Exhibit 106: Data Table on China - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 107: Market opportunity by geography ($ million)
      • Exhibit 108: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 109: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 111: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 112: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 113: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 114: Matrix on vendor position and classification
            • 12.3 AbbVie Inc.
              • Exhibit 115: AbbVie Inc. - Overview
              • Exhibit 116: AbbVie Inc. - Product / Service
              • Exhibit 117: AbbVie Inc. - Key news
              • Exhibit 118: AbbVie Inc. - Key offerings
            • 12.4 Acerus Pharmaceuticals Corp.
              • Exhibit 119: Acerus Pharmaceuticals Corp. - Overview
              • Exhibit 120: Acerus Pharmaceuticals Corp. - Product / Service
              • Exhibit 121: Acerus Pharmaceuticals Corp. - Key offerings
            • 12.5 Alembic Pharmaceuticals Ltd.
              • Exhibit 122: Alembic Pharmaceuticals Ltd. - Overview
              • Exhibit 123: Alembic Pharmaceuticals Ltd. - Product / Service
              • Exhibit 124: Alembic Pharmaceuticals Ltd. - Key offerings
            • 12.6 Amneal Pharmaceuticals Inc.
              • Exhibit 125: Amneal Pharmaceuticals Inc. - Overview
              • Exhibit 126: Amneal Pharmaceuticals Inc. - Business segments
              • Exhibit 127: Amneal Pharmaceuticals Inc. - Key news
              • Exhibit 128: Amneal Pharmaceuticals Inc. - Key offerings
              • Exhibit 129: Amneal Pharmaceuticals Inc. - Segment focus
            • 12.7 Bausch Health Companies Inc.
              • Exhibit 130: Bausch Health Companies Inc. - Overview
              • Exhibit 131: Bausch Health Companies Inc. - Business segments
              • Exhibit 132: Bausch Health Companies Inc. - Key news
              • Exhibit 133: Bausch Health Companies Inc. - Key offerings
              • Exhibit 134: Bausch Health Companies Inc. - Segment focus
            • 12.8 Bayer AG
              • Exhibit 135: Bayer AG - Overview
              • Exhibit 136: Bayer AG - Business segments
              • Exhibit 137: Bayer AG - Key news
              • Exhibit 138: Bayer AG - Key offerings
              • Exhibit 139: Bayer AG - Segment focus
            • 12.9 Cipla Ltd.
              • Exhibit 140: Cipla Ltd. - Overview
              • Exhibit 141: Cipla Ltd. - Business segments
              • Exhibit 142: Cipla Ltd. - Key news
              • Exhibit 143: Cipla Ltd. - Key offerings
              • Exhibit 144: Cipla Ltd. - Segment focus
            • 12.10 Eli Lilly and Co.
              • Exhibit 145: Eli Lilly and Co. - Overview
              • Exhibit 146: Eli Lilly and Co. - Product / Service
              • Exhibit 147: Eli Lilly and Co. - Key news
              • Exhibit 148: Eli Lilly and Co. - Key offerings
            • 12.11 Endo International Plc
              • Exhibit 149: Endo International Plc - Overview
              • Exhibit 150: Endo International Plc - Business segments
              • Exhibit 151: Endo International Plc - Key news
              • Exhibit 152: Endo International Plc - Key offerings
              • Exhibit 153: Endo International Plc - Segment focus
            • 12.12 Ferring BV
              • Exhibit 154: Ferring BV - Overview
              • Exhibit 155: Ferring BV - Product / Service
              • Exhibit 156: Ferring BV - Key offerings
            • 12.13 Halozyme Therapeutics Inc.
              • Exhibit 157: Halozyme Therapeutics Inc. - Overview
              • Exhibit 158: Halozyme Therapeutics Inc. - Product / Service
              • Exhibit 159: Halozyme Therapeutics Inc. - Key offerings
            • 12.14 Marius Pharmaceuticals
              • Exhibit 160: Marius Pharmaceuticals - Overview
              • Exhibit 161: Marius Pharmaceuticals - Product / Service
              • Exhibit 162: Marius Pharmaceuticals - Key offerings
            • 12.15 Pfizer Inc.
              • Exhibit 163: Pfizer Inc. - Overview
              • Exhibit 164: Pfizer Inc. - Product / Service
              • Exhibit 165: Pfizer Inc. - Key news
              • Exhibit 166: Pfizer Inc. - Key offerings
            • 12.16 Sawai Pharmaceutical Co. Ltd.
              • Exhibit 167: Sawai Pharmaceutical Co. Ltd. - Overview
              • Exhibit 168: Sawai Pharmaceutical Co. Ltd. - Business segments
              • Exhibit 169: Sawai Pharmaceutical Co. Ltd. - Key offerings
              • Exhibit 170: Sawai Pharmaceutical Co. Ltd. - Segment focus
            • 12.17 Teva Pharmaceutical Industries Ltd.
              • Exhibit 171: Teva Pharmaceutical Industries Ltd. - Overview
              • Exhibit 172: Teva Pharmaceutical Industries Ltd. - Business segments
              • Exhibit 173: Teva Pharmaceutical Industries Ltd. - Key news
              • Exhibit 174: Teva Pharmaceutical Industries Ltd. - Key offerings
              • Exhibit 175: Teva Pharmaceutical Industries Ltd. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 176: Inclusions checklist
                • Exhibit 177: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 178: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 179: Research methodology
                • Exhibit 180: Validation techniques employed for market sizing
                • Exhibit 181: Information sources
              • 13.5 List of abbreviations
                • Exhibit 182: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              testosterone replacement therapy market market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis